Search

everythinglearnresearchcommunity

for

Search:↓

The bulletin provides guidelines for diagnosing and managing PCOS, suggesting weight loss, hormonal contraceptives, and diabetes screening, with clomiphene for infertility and various treatments for excess hair.

Oxidative stress is a key factor in the development of Polycystic Ovary Syndrome, and weight management can improve symptoms.

The document says that understanding the causes of PCOS is important for treatment, especially in distinguishing the syndrome from just having cystic ovaries, and that losing weight is key for obese women with PCOS.

Women have a higher risk of blood clots from hormonal factors and need careful treatment, especially during pregnancy.

Testosterone conversion to 5α-DHT may not be essential for its effects on the skin.

Rat skin takes up and processes testosterone differently than other organs, with testosterone being more important for the skin than its metabolite 5α-DHT.

The document concludes that early diagnosis and treatment of PCOS in teenagers is important for managing symptoms and preventing long-term health problems.

Wedelolactone selectively kills prostate cancer cells without harming normal cells.

Mitoxantrone with a corticosteroid helps manage symptoms for some advanced prostate cancer patients but doesn't extend life.

Circadian rhythm disruption, chronic inflammation, hormones, metabolism, and genetics may increase prostate cancer risk.

Finasteride and dutasteride are equally effective and safe for treating benign prostatic hyperplasia.

Finasteride before TURP reduces blood loss and slightly improves early postoperative quality of life.

Diabetes may lower the risk of prostate cancer.

Finasteride is popular for treating male hair loss but may increase the risk of serious prostate cancer and has other potential side effects.

Higher BMI and lower testosterone are linked to more aggressive prostate cancer.

Plant-based compounds might be a promising alternative for prostate cancer treatment with fewer side effects.

Phytochemicals may offer safer alternatives to synthetic drugs for prostate cancer treatment.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

Off-label drug use can be risky and requires careful consideration to ensure patient safety.

5α-reductase inhibitors effectively treat enlarged prostate and hair loss but require careful use due to possible side effects.

Men with higher body mass index (BMI) in Taiwan tend to have more severe hair loss.

Testosterone can build muscle and bone without enlarging the prostate when a specific enzyme is blocked.

Testosterone may influence COVID-19 severity and outcomes.

Higher testosterone levels can increase the risk of certain diseases like type 2 diabetes in women and prostate cancer in men, but can also protect against autoimmune diseases and hair loss. It also affects body fat and bone density.

A new method accurately measures nine specific hormones in human blood.

The study created a model to help design new inhibitors for steroidal 5α-reductase enzymes.

Men on 5-alpha-reductase inhibitors might have worse COVID-19 outcomes.

Combination therapy for BPH is cost-effective, especially for men with larger prostates.

Omega-6 fats in certain cells boost male hormone production.

UHP-sCESr is as effective as HESr for treating BPH symptoms.